募捐 9月15日2024 – 10月1日2024 关于筹款

Tamoxifen: Pioneering Medicine in Breast Cancer

Tamoxifen: Pioneering Medicine in Breast Cancer

Philipp Y. Maximov, Russell E. McDaniel, V. Craig Jordan (auth.)
你有多喜欢这本书?
下载文件的质量如何?
下载该书,以评价其质量
下载文件的质量如何?

Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. It is the first drug targeted therapy in cancer to be successful. Tamoxifen targets the tumor estrogen receptor. The therapy is known to have saved the lives of millions of women over the past 40 years.

This monograph, written by V. Craig Jordan - known as the “father of tamoxifen” - and his Tamoxifen Team at the Georgetown University Washington DC, illustrates the journey of this milestone in medicine. It includes a personal interview with V. Craig Jordan about his four decades of discovery in breast cancer research and treatment. V. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a “failed morning after contraceptive” to become the “gold standard” for the treatment of breast cancer. He contributed to every aspect of tamoxifen application in therapeutics and all aspects of tamoxifen’s pharmacology. He discovered the selective estrogen receptor modulators (SERMs) and explored the new biology of estrogen-induced apoptosis.

种类:
年:
2013
出版:
1
出版社:
Springer Basel
语言:
english
页:
202
ISBN 10:
3034806647
ISBN 13:
9783034806640
系列:
Milestones in Drug Therapy
文件:
PDF, 3.06 MB
IPFS:
CID , CID Blake2b
english, 2013
因版权方投诉,本书无法下载

Beware of he who would deny you access to information, for in his heart he dreams himself your master

Pravin Lal

关键词